Volume 73 Number 3 May 2006	back to contents

Professor Emerita of Genetics, Louisiana State University Health Science Center, New Orleans, LA, and GenELSI Consulting, Inc., New Orleans, LA.

Address all correspondence to Dr. Pelias, Professor Emerita of Genetics, L.S.U.H.S.C., GenELSI Consulting, Inc., 1025 State Street, New Orleans, LA 70118.

Presented at Cancer Genetics for the Clinician, Moffitt Cancer Center & Research Institute, Tampa, FL, March 6–8, 1998; and “Special Challenges for Pediatrics” at the Mount Sinai School of Medicine, New York, NY on January 30, 2004, and updated April 2005.

Abstract

Questions related to testing children for adult-onset genetic diseases include many variables that generate different answers among different families. These issues include the biological nature of specific genes, concern about what benefits or harms may accrue from testing children, possible psychosocial sequelae, and ethical and legal concerns about personal autonomy. The shift in the physician-patient relationship from professional beneficence to patient autonomy has established the patient, or parents, as the primary decision-makers in questions about treatment or testing options. The role of parents as decision-makers for their own minor children has been reinforced by four seminal holdings of the United States Supreme Court. Assertions about protecting the future autonomy of children are invalid because minor children are not autonomous. Their parents, on the other hand, have a right—and perhaps even a duty—to exercise their own vested autonomy in making decisions that they believe are in the best interests of their own families. Geneticists are urged to provide clear and complete counseling to parents who seek testing for their children, and then defer to the parents as the primary decision-makers for their own minor children.

Key Words

Genetic testing, children, adult-onset disease.

MSSM Home

Back Issues | Indexes | Search | Journal Home